172 related articles for article (PubMed ID: 38168442)
1. Feasibility of adjuvant self-administered intravaginal 5-fluorouracil cream following primary treatment of cervical intraepithelial neoplasia grade 2 or 3 among women living with HIV in Kenya: study protocol for a pilot trial.
Mungo C; Bukusi E; Kirkland GE; Ogollah C; Rota G; Omoto J; Rahangdale L
medRxiv; 2023 Dec; ():. PubMed ID: 38168442
[TBL] [Abstract][Full Text] [Related]
2. Safety and adherence to self-administered intravaginal 5-fluorouracil cream following cervical intraepithelial neoplasia (CIN) 2/3 treatment among HIV-positive women in Kenya: A phase 1 clinical trial.
Mungo C; Omoto J; Ogollah C; Owaya A; Rop M; Rota G; Bukusi EA; Tang J; Rahangdale L
medRxiv; 2024 Jun; ():. PubMed ID: 38883743
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of thermal ablation for treatment of biopsy-confirmed high-grade cervical precancer among women living with HIV in Kenya.
Mungo C; Osongo CO; Ambaka J; Omoto J; Cohen CR
Int J Cancer; 2023 Dec; 153(12):1971-1977. PubMed ID: 37715464
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. "ARVs is for HIV and cream is for HPV or precancer:" Women's Perceptions and Perceived Acceptability of Self-Administered Topical Therapies for Cervical Precancer Treatment: A Qualitative Study from Kenya.
Mungo C; Kachoria AG; Adoyo E; Zulu G; Goraya SK; Omoto J; Osongo C; Ferrari RM
medRxiv; 2024 Mar; ():. PubMed ID: 38559146
[TBL] [Abstract][Full Text] [Related]
6. Effect of Cryotherapy vs Loop Electrosurgical Excision Procedure on Cervical Disease Recurrence Among Women With HIV and High-Grade Cervical Lesions in Kenya: A Randomized Clinical Trial.
Greene SA; De Vuyst H; John-Stewart GC; Richardson BA; McGrath CJ; Marson KG; Trinh TT; Yatich N; Kiptinness C; Cagle A; Nyongesa-Malava E; Sakr SR; Mugo NR; Chung MH
JAMA; 2019 Oct; 322(16):1570-1579. PubMed ID: 31638680
[TBL] [Abstract][Full Text] [Related]
7. A randomized clinical trial comparing cervical dysplasia treatment with cryotherapy vs loop electrosurgical excision procedure in HIV-seropositive women from Johannesburg, South Africa.
Smith JS; Sanusi B; Swarts A; Faesen M; Levin S; Goeieman B; Ramotshela S; Rakhombe N; Williamson AL; Michelow P; Omar T; Hudgens MG; Firnhaber C
Am J Obstet Gynecol; 2017 Aug; 217(2):183.e1-183.e11. PubMed ID: 28366730
[TBL] [Abstract][Full Text] [Related]
8. Human Papillomavirus Persistence and Association With Recurrent Cervical Intraepithelial Neoplasia After Cryotherapy vs Loop Electrosurgical Excision Procedure Among HIV-Positive Women: A Secondary Analysis of a Randomized Clinical Trial.
Chung MH; De Vuyst H; Greene SA; Mugo NR; Querec TD; Nyongesa-Malava E; Cagle A; Sakr SR; Luchters S; Temmerman M; Unger ER; McGrath CJ
JAMA Oncol; 2021 Oct; 7(10):1514-1520. PubMed ID: 34351377
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of 5-fluorouracil and imiquimod for the topical treatment of cervical intraepithelial neoplasias (CIN) 2/3.
Desravines N; Hsu CH; Mohnot S; Sahasrabuddhe V; House M; Sauter E; O'Connor S; Bauman JE; Chow HS; Rahangdale L
Int J Gynaecol Obstet; 2023 Dec; 163(3):862-867. PubMed ID: 37431689
[TBL] [Abstract][Full Text] [Related]
10. Feasibility and Acceptability of Smartphone-Based Cervical Cancer Screening Among HIV-Positive Women in Western Kenya.
Mungo C; Osongo CO; Ambaka J; Randa MA; Samba B; Ochieng CA; Barker E; Guliam A; Omoto J; Cohen CR
JCO Glob Oncol; 2021 May; 7():686-693. PubMed ID: 33999653
[TBL] [Abstract][Full Text] [Related]
11. Vaginal 5-fluorouracil for high-grade cervical dysplasia in human immunodeficiency virus infection: a randomized trial.
Maiman M; Watts DH; Andersen J; Clax P; Merino M; Kendall MA
Obstet Gynecol; 1999 Dec; 94(6):954-61. PubMed ID: 10576182
[TBL] [Abstract][Full Text] [Related]
12. Safety and Acceptability of Thermal Ablation for Treatment of Human Papillomavirus Among Women Living With HIV in Western Kenya.
Mungo C; Osongo CO; Ambaka J; Randa MA; Omoto J; Cohen CR; Huchko M
JCO Glob Oncol; 2020 Jul; 6():1024-1033. PubMed ID: 32634066
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
[TBL] [Abstract][Full Text] [Related]
14. TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC trial): study protocol for a randomized controlled trial.
Koeneman MM; Kruse AJ; Kooreman LFS; Zur Hausen A; Hopman AHN; Sep SJS; Van Gorp T; Slangen BFM; van Beekhuizen HJ; van de Sande M; Gerestein CG; Nijman HW; Kruitwagen RFPM
BMC Cancer; 2016 Feb; 16():132. PubMed ID: 26897518
[TBL] [Abstract][Full Text] [Related]
15. TOPical Imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia (TOPIC-2 trial): a study protocol for a randomized controlled trial.
van de Sande AJM; Koeneman MM; Gerestein CG; Kruse AJ; van Kemenade FJ; van Beekhuizen HJ
BMC Cancer; 2018 Jun; 18(1):655. PubMed ID: 29902979
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the ScreenFire and Xpert HPV assays for the detection of human papillomavirus and cervical precancer among women living with HIV in Malawi.
Mungo C; Guliam A; Chinula L; Inturrisi F; Msowoya L; Mkochi T; Jawadu S; de Sanjosé S; Schiffman M; Tang JH; Smith JS
medRxiv; 2024 Feb; ():. PubMed ID: 38617305
[TBL] [Abstract][Full Text] [Related]
17. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the ScreenFire and Xpert HPV assays for the detection of human papillomavirus and cervical precancer among women living with HIV in Malawi.
Mungo C; Guliam A; Chinula L; Inturrisi F; Msowoya L; Mkochi T; Jawadu S; de Sanjosé S; Schiffman M; Tang JH; Smith JS
Infect Agent Cancer; 2024 May; 19(1):24. PubMed ID: 38760798
[TBL] [Abstract][Full Text] [Related]
19. Multiple High-Risk HPV Types Contribute to Cervical Dysplasia in Ugandan Women Living With HIV on Antiretroviral Therapy.
Nakisige C; Adams SV; Namirembe C; Okoche L; Ferrenberg J; Towlerton A; Larsen A; Orem J; Casper C; Frenkel L; Uldrick TS
J Acquir Immune Defic Syndr; 2022 Jul; 90(3):333-342. PubMed ID: 35195571
[TBL] [Abstract][Full Text] [Related]
20. Incidence of cervical dysplasia and cervical cancer in women living with HIV in Denmark: comparison with the general population.
Thorsteinsson K; Ladelund S; Jensen-Fangel S; Katzenstein TL; Johansen IS; Pedersen G; Junge J; Helleberg M; Storgaard M; Obel N; Lebech AM
HIV Med; 2016 Jan; 17(1):7-17. PubMed ID: 26058995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
